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improves overall DTB time and transfer time. In addition, it has the potential to decrease
the frequency of false activations, therefore improving cost-efficiency of a network’s
STEMI system.
TCT-113
Focal Treatment of Lower Extremity Post-PTA Dissection Using The Tack-It
Endovascular Staple Device: First-in-man Trial With One Year Follow-up
Peter Schneider1, Adrian Ebner2, Robert Giasolli3
1Kaiser Hawaii, Honolulu, HI, 2Italian Hospital, Asuncion, Paraguay, 3Intact
Vascular, Wayne, PA
Background: The purpose of this study was to evaluate the safety, feasibility, and results
of using the Tack-It Endovascular Stapler™ to manage post-PTA dissection. Stents are
used to manage of post-PTA dissection of the lower extremity arteries. This generally
provides an acceptable post-intervention angiographic result but has long-term disadvan-
tages such as in-stent restenosis and fracture. Focal treatment of post-PTA dissection and
avoidance of stent placement in this setting is the function of the Tack-It device.
Methods: A total of 15 limbs (11 patients) with 25 lesion treatment sites were treated
with the study device between December, 2009 and March, 2010. In the study group, 7
subjects had lesion treatments in one leg and 4 subjects had lesion treatments treated in
bilateral extremities for lesions of the SFA, popliteal, or tibial arteries or a combination of
these. Indications were CLI in 9 of the 15 limbs and claudication in 6.
Results: Acute technical success for luminal patency at the end of the study procedure
was achieved with Tack placement and tissue apposition in 100% of all treated
dissections. 50 Tacks were placed and placement was accurate in 96% (48/50). Tack
placement successfully provided a smooth, post-angioplasty blood vessel surface and
permanently secured post-PTA dissections. Mean procedure time was 51 minutes (range
10 – 128 minutes). Mean fluoroscopy time was 13 minutes (range 5 – 30 minutes). Two
patients died and 2 were lost to follow-up during the year after the procedure. There were
no device related complications. There were no major limb amputations. 18 of the 25
lesions were available for follow-up at one year. There was recurrent stenosis (50%) in
3 of 18. One patient with gangrene and a popliteal occlusion returned with a recurrent
stenosis at 3 months and required repeat angioplasty and Tack placement for a TLR rate
of 4%. Overall angiographic patency at one year was 83.3%.
Conclusions: Use of the Tack-It Endovascular Stapler™ to manage post-PTA dissec-
tions is safe and feasible, and resulted in permanent securement of dissection flaps without
stent placement and with reasonable angiographic patency at one-year.
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Feasibility of Noninvasive Atherectomy: Plaque Ablation with Cavitation-
Based Focused Ultrasound (Histotripsy)
Adam Maxwell1, Zhen Xu1, Hitinder Gurm1
1University of Michigan, Ann Arbor, MI
Background: Histotripsy is a novel technique that uses high-amplitude focused ultra-
sound pulses to create cavitation in a targeted tissue, with resultant mechanical breakdown
of the tissue structure. Ultrasound imaging provides feedback for the therapy, including
targeting and monitoring treatment progression. We assessed the feasibility of histotripsy
for ablating large vessel plaque.
Methods: Human plaque specimens obtained from carotid or femoral endarterectomy
were fixed to a gelatin substrate and placed in a water tank. In 4 samples, the focus was
scanned within the plaque to try to create a channel through it. In 3 samples, multiple fixed
focal ablations were performed to evaluate erosion rate. Histological analysis was
performed post treatment to examine ablation efficacy for different plaque types.
Results: Tissue breakdown was evident in most samples. Cavitation was observed by
B-Mode imaging on the surface or within the plaque volume during treatment, indicating
the region of disruption. Channels up to 1 cm were created within the bulk of the plaque.
Ablation rate was strongly dependent on plaque type: fatty material could be ablated
within a few seconds in the focus, while very fibrous material required5-15 minutes per
focal volume. No damage was observed to calcific material. The figure shows gross
morphology (left) and histology (right) of a channel created adjacent to the lumen in a
fibrous-fatty plaque.
Conclusions: Histotripsy provides a noninvasive method of ablation of atherosclerotic
plaque. We are currently exploring the feasibility of this technique for treatment of
femoral-popliteal disease.
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Hybrid endovascular repair for aortic arch pathology: intermediate outcomes
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Background: To evaluate the outcomes of hybrid endovascular repair for aortic arch
pathology.
Methods: This study was a retrospective analysis involving patients who underwent
hybrid endovascular repair for aortic arch pathologies.
Results: Twenty-one patients (16 men; mean age, 64.716.2 years) with aortic arch
pathologies were treated by hybrid endovascular repair. The indications for treatment
included increased aneurysm size in 16 cases (71.4%), rupture or impending aneurysmal
rupture in 5 cases (23.8%), and rapid growth of aortic dissection ( 10mm/y) in 1 case
(4.8%). Supra-aortic vessel transposition and stent-graft implantation were achieved in all
cases. Two types of stent-graft was used, as follows: the Seal thoracic stent-graft in 14
patients (66.7%); and the Valiant stent grafts in 7 patients (33.3%). Peri-operative
complications affected 5 patients (23.8%), as follows: bleeding (n4, 19.0%); stroke
(n3, 14.3%); renal failure (n2, 9.5%); vascular injury (n1, 4.8%), and respiratory
failure (n1, 4.8%). Two patients died within 30 days (9.5%). Technical success was
achieved in 15 patients (71.5%). Early endoleaks were noted in 4 patients (19.0%). One
patient died during follow-up (mean, 21.311.6 months) due to a de novo aortic
dissection. Persistent early endoleaks were noted in 4 patients (19.0%); 2 of the 4 patients
were successfully managed with implantation of additional stent-grafts. No late onset
endoleaks were noted.
Conclusions: Hybrid treatment with supra-aortic vessel transposition and endovascular
repair may be an option in frail patients in who open procedures is too risky.
TCT-116
A New Concept Of Stent: The Multilayer Flow Modulator. First Human
Study In Thoraco Abdominal And Abdominal Aortic Aneurysms.
Michel Henry1, Amira Benjelloun2, Isabelle Henry3
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Background: Thoraco Abdominal Aortic Aneurysms (TAAA) and Abdominal Aortic
Aneurysms (AAA) are traditionally treated surgically, but more and more by interven-
tional procedures (endografts, fenestrated grafts) with a high technical success rate but
high complications rate (mortality 9-12%, endoleacks 10-20%, branch occlusion 3-11%,
neurological complications 5-11%). We developed a new concept of stent, the Multilayer
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Flow Modulator (M.F.M) to treat these aneurysms and try to avoid some major
complications.
Methods: This M.F.M is a 3 Dimensional braided tube made of several interconnected
layers without any covering. Our earlier tests through studies as theorical simulation,
computerized Fluid Dynamics, Molecular Modelization, Finite Elements Analysis and
through in vivo tests demonstrate that in an Aortic Aneurysm this M.F.M: - eliminates the
damaging flow vortex pressure, - laminates and redirects its flow along the wall, - directs
and increases the flow in the collateral branches which remain patent (any artery can be
covered with the stent without compromising the flow). This MFM prevents the
aneurismal rupture and leads to progressive thrombosis and shrinkage of this aneurysm.
Results: 9 TAAA, 5 AAA (4 extended to both iliac arteries) in 14 very high risk
compassionate cases (Male: 12, mean age 66 y.) were treated with the MFM. Technical
success: 100%. Average MFM used: 1 to 4 units implanted by femoral approach. No
periprocedural complications. - 30 day outcomes ● Branch patency 100% ● No death ●
Neurological complications: 0 - Follow up: 1 to 36 months ● 2 deaths at M6 M8 not stent
related (stroke) ● Branch patency: 100% ● Progressive sac thrombosis and shrinkage
depending on importance of collaterals. Diameters and volume evolution of aneurysms
will be presented.
Conclusions: A new concept of stent, the MFM (without any covering) is developed to
treat aneurysms. It laminates the flow inside the aneurismal sac reducing the risk of
rupture and allows to cover any artery. It opens a new approach to treat TAAA and AAA.
The first results seem promising, avoiding some major complications encountered with
endografts. A larger study is ongoing.
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Peri-procedural and Follow up Outcomes after Endovascular Abdominal
Aortic Aneurysm Repair by Interventional Cardiologists
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Background: Endovascular repair of abdominal aortic aneurysm (AAA) is a minimally
invasive treatment for AAA and has recently been made a class I indication in the
treatment of AAA. In comparison to the conventional open surgical treatment, endovas-
cular AAA repair (EVAR) is associated with equivalent long-term morbidity and
mortality rates. Vascular surgeons perform majority of EVAR. There are no reports for the
long-term results of this intervention performed by Interventional Cardiologists. We
hypothesized that EVAR performed by Interventional Cardiologists can have good
peri-procedural and long-term success rates.
Methods: Retrospective chart review on patients with attempted EVAR between
September 2005 and January 2011 was performed. Included cases were all consecutive
patients who had attempted EVAR by Interventional Cardiologists with available on site
Vascular Surgery support. Data collection included demographics, aneurysm specific
data, comorbidities, length of stay, peri-procedural complications and follow up out-
comes.
Results: During the study period EVAR was attempted in 170 patients, with 27% being
women. The mean age was 72.1 years (range 52 to 93). The endovascular graft placement
was successful in 96% (163/170) of patients. Procedure failures were more common in
women (6 of 46 Vs 1 of 124, p  0.002). In 5 patients the device could not be deployed
successfully due to unfavorable anatomy. The 30-day mortality was 1.8 % (3 of 170). In
patients with successful EVAR the mean follow up was 30 months (range 2 to 66 months)
and mean length of hospital stay was 3.5	/ 3.2 days. Major peri-procedural compli-
cations were noted in 7% patients (12 of 167). During follow up, five patients (3%)
required re-intervention and additional 16 patients died with no aneurysm related deaths.
Conclusions: This is the one of the first reports of EVAR primarily performed by
Interventional Cardiologists, which demonstrates high peri-procedural and long-term
success rates. A higher EVAR failure rate has been observed in women. EVAR can have
a significant place in a successful Interventional Cardiology practice.
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Background: Conventionally, inclusion criteria for endovascular AAA repair (EVAR)
include 15 mm aortic neck length and exclusion criteria include increased proximal
angulations. Typically, short-necked aneurysms display increased proximal angulations,
hence increasing the complexity of EVAR. Recently, updated EVAR techniques have
been used for the treatment of short-necked and juxtarenal AAA. There are no reports
regarding the short and long term outcomes of this intervention for short-necked
aneurysms primarily performed by Interventional Cardiologists.
Methods: Retrospective chart review was performed on all patients with attempted
EVAR between September 2005 and January 2011. Short-necked AAA was defined as
15 mm length of normal aorta below the lowest renal artery.
Results: EVAR was attempted in 170 consecutive AAA patients, with 11% (18 of 170)
being short necked. Women comprised 28% in both the groups (5 of 18 Vs 42 of 152;
pNS). Baseline characteristics and follow-up duration were similar in both groups.
Three patients died within 30 days and endograft delivery was not successful in an
additional 4 patients. Procedural failures were more common in women (6 of 46 Vs 1 of
124, p 0.002). There was no significant difference for failure rate based on neck length
(0 of 18 Vs 7 of 152; pNS). Short-necked aneurysms required non-covered balloon
expandable stents more commonly for either proper fixation or for type I endoleak (16 of
18 Vs 25 of 152; p0.001). In patients with successful EVAR the mean follow up was
30 months (range 2 to 66). Major peri-procedural complications were noted in 7% patients
(12 of 167). There was no significant difference in short necked and other AAA in terms
of 30-day mortality, development of renal failure, leg ischemia, development of endoleaks
or other complications. During follow up, re-intervention was needed in 0 of 18
short-necked Vs 5 of 152 other AAA (pNS).
Conclusions: Modifying EVAR by using balloon expandable stents can successfully
treat short-necked AAA, suggesting a potential novel approach to such patients. This is
one of the first reports showing high peri-procedural and long-term success rates for such
aneurysms performed by Interventional Cardiologists.
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The Clinical Significance Of Coronary Angiography In Elderly Patients
Undergoing Endovascular Repair For Type B Aortic Dissection
Pengcheng He1, Jiyan Chen1, Jianfang Luo2, Nin Tan1
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Background: Although sharing some common risk factors with and predicting worse
prognosis of type B aortic dissection,the incidence of concomitant coronary artery disease
in patients with type B dissection has not been studied comprehensively.
Methods: From January 2008 to December 2010, coronary angiography was routinely
performed before aortography and endovascular repair to detect and quantify CAD in 134
consecutive Standford type B AD patients who were older than 50 years.Data pertaining
to clinical and imaging details were prospectively collected and evaluated.2 test,or the
Fisher exact test when the expected frequency was 5,was used to analyses the data
Logistic regression was applied to determine the predictors of concomitant CAD.
Results: Coronary angiography showed 35 patients (26.1%) had CAD,among them,22
(16.4%) had single-vessel disease (SVD), 9 (6.7%) had 2VD(BVD) , 4 (3.0%) had
3VD(TVD) or left main disease (LM). Multi-variance logistic analysis showed that male
gender (OR6.682,95% CI:1.01-44.13,p0.049) and smoking (OR3.513, 95% CI:
1.05-11.70, p0.041) were the strongest predictors of Standford type B AD coexisted
with CAD.
Conclusions: The incidence of CAD in patients older than 50 years with Standford type
B AD is relatively high.Given the significantly negative impact on the prognosis,con-
comitant coronary artery disease should be screened routinely by coronary angiography
before endovascular repair in type B dissection patients who are older than 50 years.
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The Policy Of Total Percutaneous Abdominal Aortic Aneurysm Repair: One-
year Follow-up
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Background: Endovascular abdominal aortic aneurysm repair (EVAR) is accepted
therapeutic strategy. The use of a total percutaneous approach to endovascular repair of
aortic pathology is becoming more common and further extends the EVAR indications.
The aim of our retrospective analysis was assessment of safety, technical success, and
mid-term results of elective patients scheduled for total percutaneous EVAR implantation
(PEVAR).
Methods: Sixty-two consecutive patients (M:F 57:5, age 709 years, maximal AAA
diameter 6114mm) underwent elective PEVAR between 1/2009 and 12/2010. All
patients were treated in local anesthesia by total percutaneous approach via femoral access
using the preclose technique with the Prostar XL suture-mediated closure device (Abbott
Vascular, US). The immediate technical success of stentgraft implantation, and the
presence of 30-days and 1-year complication rate were assessed.
Results: In all 62 patients (100%) there was immediate technical success of procedure,
with no need of conversion to open surgery. There was one case of prerenal failure (1.6%),
and one case of acute bowel ischemia (1.6%) at 30-days follow-up. Repeat intervention
was needed in 8% (5pts). Event-free survival at 30-days was 89% (55/62pts). There were
16 cases of the femoral artery pseudoaneurysm per 124 punctures (13%), all treated by
compression or by percutaneous thrombin injection. Anticoagulation therapy emerged as
the risk factor for the femoral artery pseudoaneurysm occurrence (OR 5.75, 95% CI
1.89-17.5, p0.003). At one-year follow-up period the mortality increased to 9.6% (6
pts), overall event-free survival was 81% (mortality/MI/stroke/reintervention/ severe
ischemic complication).
Conclusions: The policy of total percutaneous endovascular abdominal aortic aneurysm
repair is linked with low mortality and acceptable complication rate in pts scheduled for
EVAR implantation. Anticoagulation therapy is the risk factor for the femoral artery
pseudoaneurysm occurrence after PEVAR. The correct indication, technical realization,
and adequate periprocedural management are essential for further reduction of adverse
events after PEVAR.
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